Salim Yazji Oncternal Therapeutics, Inc. (ONCT) insider trading activity
Salim Yazji is Chief Medical Officer of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 128,635 shares of ONCT, which is worth approximately $146,643. The most recent transaction as insider was on Jan 03, 2024, when has been sold 19,742 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $9,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
129K
0%
3M change
13.31%
12M change
Total Value Held
$146,643
Salim Yazji Transaction History
SY
Salim Yazji
Chief Medical Officer
San Diego, CA